Can a GCP document be e-signed?

Yes. Electronic signatures meet U.S. legal standards under the ESIGN Act (15 U.S.C. §7001) and state UETA laws for most documents; confirm whether the document type is an ESIGN exception such as certain court filings or testamentary instruments.

Is electronic consent acceptable for clinical studies?

Electronic informed consent is permissible when the process documents intent, consent, attribution, and retention. Follow FDA and IRB guidance and ensure systems meet 21 CFR Part 11 where required.

What about HIPAA and PHI in documents?

If the document contains PHI, use a vendor under a signed BAA, limit access by role, and apply encryption and logging consistent with HIPAA; retention follows 45 CFR §164.530(j).

How long must signed records be kept?

Follow applicable federal baselines: HIPAA records six years (45 CFR §164.530(j)) and IRS-related records three years (IRC §6501(a)); FDA-regulated studies may have additional retention obligations.

Who qualifies to sign on behalf of an investigator?

Authorized signers are those with documented delegation in the delegation of duties log; institutional policies and sponsor agreements determine permitted surrogate signers.

Can I use Remote Online Notarization (RON)?

Maybe. RON availability varies by state and document type; verify state RON status, identity-proofing, and audio-video recording retention requirements before proceeding.

Electronic Signature
Templates
Healthcare
Healthcare GCP Document

Healthcare GCP Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE GCP DOCUMENT

Study and Site Identification

Study Title:

Study ID / Protocol Number: Investigator/Site:

Participant Information

Full legal name Date of birth

Gender: Female Male Other / Prefer not to say

Address Primary phone Emergency contact (name, relationship, phone)

Insurance Information

Insurance provider Policy number Group number (if applicable) Subscriber name (if not participant)

Medical History and Current Health

Current medications (include dose & frequency) Allergies (drug, food, environmental) Prior surgeries / hospitalizations (with approximate dates) Chronic conditions / ongoing diagnoses

Study Procedures, Risks, and Benefits

Brief description of study procedures

Risks and potential adverse effects: The investigator has explained the reasonably foreseeable risks, discomforts, and potential adverse effects associated with participation, including procedures specific risks and unknown long-term risks. I acknowledge that serious adverse events may occur and that I will report symptoms immediately to study personnel.

Participant acknowledges review of risks and benefits

I acknowledge that the risks, benefits, and alternatives have been explained to me and that I have had the opportunity to ask questions.

Voluntary Participation and Withdrawal

Participation is voluntary. I understand I may refuse to participate or may withdraw from the study at any time without penalty or loss of benefits to which I am otherwise entitled. Withdrawal will not affect my access to usual medical care. If I withdraw, I may be asked whether existing data and specimens already collected may continue to be used; I understand how those choices affect my data.

Confidentiality, Data Use, and HIPAA Authorization

I authorize the use and disclosure of my protected health information (PHI) for purposes of this research. PHI to be disclosed may include medical records, laboratory results, imaging, and study-specific data. Recipients may include the sponsor, monitoring and auditing organizations, institutional review boards, and regulatory agencies. Identifiers may be removed for secondary research; however, de-identified data or specimens may be stored and used for future research as permitted by law.

I understand that I may revoke this authorization at any time by submitting a written revocation to the study site; revocation will not affect disclosures already made in reliance on this authorization prior to receipt of the revocation. Unless revoked earlier, this authorization will expire on the date specified below or upon completion of the study and any analysis that uses my data, whichever occurs later.

Authorization expiration date

I consent to the collection, storage, and research use of biological specimens (if applicable) and agree that such specimens may be stored for future research in a coded or de-identified form.

I authorize the storage and future research use of biological specimens and de-identified data as described above.

Participant Certification

By signing below I certify that: (1) I have read and understand the information in this document; (2) the study, its purpose, procedures, risks, benefits, and alternatives have been explained to me; (3) I have had the opportunity to ask questions and receive answers; (4) I understand that I may be contacted for follow-up as part of the study; and (5) I freely consent to participate in this research under Good Clinical Practice principles and applicable regulations.

Initials (participant): Date of initial consent:

Contacts for Questions and Reporting

Study contact for questions or to report an adverse event Alternate contact (site office or clinical trials office)

Participant Signature

Patient Name:

Signature:

Date:

If signed by legal representative or guardian: Relationship to participant:

Legal representative printed name (if applicable):

What the Healthcare GCP Document Is and Why It Matters

A Healthcare GCP Document records Good Clinical Practice elements used in clinical research and regulated healthcare studies. It typically bundles the protocol identifier, investigator responsibilities, informed consent language, monitoring plans, safety reporting procedures, signature and delegation logs, and audit-trail metadata required for regulatory review. For U.S. submissions and electronic records, the document must meet applicable standards such as FDA 21 CFR Part 11 for electronic records and signatures and HIPAA privacy/retention rules where protected health information is involved. Clear, auditable records reduce review friction during inspections and IRB oversight.

Primary Purpose and Practical Advantages

The Healthcare GCP Document centralizes protocol compliance, documents participant consent and investigator actions, and creates an auditable record for IRB and regulator review. Properly prepared documents reduce administrative delays, support data integrity, and help demonstrate adherence to FDA and HIPAA obligations without introducing unnecessary operational risk.

Who Prepares and Signs a Healthcare GCP Document

Typical preparing and signing parties span clinical operations, regulatory, and oversight roles that must coordinate content and approvals.

Clinical research coordinators and site staff — complete source data and confirm visit-level actions.
Study sponsors and CROs — approve protocol versions, safety reporting language, and delegation logs.
Institutional review boards (IRBs) and compliance officers — review consent language and sign approvals.

Roles may vary by sponsor structure and institutional policies but generally include the listed functions below.

Step-by-Step: Completing a Healthcare GCP Document

Follow these sequential steps to prepare, verify, and finalize the document for IRB and regulatory readiness.

01

Assemble Source Data: Collect protocol, consent forms, delegation logs, and SOP references.
02

Populate Fields: Enter names, dates, IDs, and study-specific values consistently.
03

Internal Review: Have regulatory and clinical leads review accuracy and compliance.
04

Execute Signatures: Obtain required signatures with authentication and timestamp evidence.

How Electronic Completion and Routing Typically Work

Electronic workflows follow predictable stages that preserve audit data and allow parallel review where permitted.

Upload Document: Sender uploads final draft to the signing platform.
Place Fields: Add signature, date, and data-entry fields where required.
Assign Signers: Specify signer roles and authentication level.
Capture Audit Trail: System records timestamps, IP, and actions for compliance.

Field	Configuration
Authentication	Use email+SMS code or enterprise SSO for signer verification
Audit Trail	Enable full action log with timestamps and IP addresses
Retention Setting	Enable immutable storage and exportable audit reports
HIPAA Controls	Require BAA and restrict PHI access by role

Platform Integrations and Technical Considerations

Choose platform features that support your clinical workflow and data systems.

CRM / ERP: Salesforce, NetSuite
Office Suites: Microsoft 365, Google Workspace
Storage / PM: Box, Egnyte, Procore

Core Sections of a Professional Healthcare GCP Document

A standard Healthcare GCP Document contains defined sections that reviewers expect; include each section clearly and consistently.

Protocol Summary

Concise protocol identifier, objectives, and primary contacts to link operational activities with the study master file.

Informed Consent

Complete consent text with patient-facing language, version number, and signatures documenting voluntary participation.

Investigator Duties

Explicit investigator responsibilities, delegation log entries, and training confirmations required for inspection.

Safety Reporting

Adverse event reporting procedures, timelines, and contacts for expedited reporting to sponsor and IRB.

Monitoring Plan

Source data verification approach, visit schedule, and escalation paths for findings.

Audit Trail & Metadata

Document creation history, version control, signer attribution, timestamps, and any change rationale.

Essential Security and Compliance Controls

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

HIPAA: BAA required for PHI handling

21 CFR Part 11: Authentication and audit trails supported

SOC 2: SOC 2 Type II report available

ISO: ISO 27001 certified controls

Accessibility: WCAG 2.0 Level AA support

Key Risks and Consequences of Poor Documentation

Regulatory Rejection: Incomplete records can cause data exclusion

Inspection Findings: FDA 21 CFR citations may follow

HIPAA Breach: Improper PHI controls risk fines

Protocol Deviations: Missed procedures can invalidate data

Delayed Enrollment: Administrative errors slow study start

Legal Exposure: Liability from inadequate consent records

eSignature Vendor Comparison for Healthcare GCP Documents

Compare common feature criteria relevant to healthcare GCP documents; signNow is listed first as a baseline. Check each vendor for plan specifics and enterprise add-ons before committing.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card required	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes (Business Premium)	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes (BAA)	Yes (BAA)	Yes (BAA)	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions and Common Issues

Answers to common questions about e-signing, retention, and regulatory acceptability for Healthcare GCP Documents.

Need help? Contact support

Can a GCP document be e-signed?
Yes. Electronic signatures meet U.S. legal standards under the ESIGN Act (15 U.S.C. §7001) and state UETA laws for most documents; confirm whether the document type is an ESIGN exception such as certain court filings or testamentary instruments.
Is electronic consent acceptable for clinical studies?
Electronic informed consent is permissible when the process documents intent, consent, attribution, and retention. Follow FDA and IRB guidance and ensure systems meet 21 CFR Part 11 where required.
What about HIPAA and PHI in documents?
If the document contains PHI, use a vendor under a signed BAA, limit access by role, and apply encryption and logging consistent with HIPAA; retention follows 45 CFR §164.530(j).
How long must signed records be kept?
Follow applicable federal baselines: HIPAA records six years (45 CFR §164.530(j)) and IRS-related records three years (IRC §6501(a)); FDA-regulated studies may have additional retention obligations.
Who qualifies to sign on behalf of an investigator?
Authorized signers are those with documented delegation in the delegation of duties log; institutional policies and sponsor agreements determine permitted surrogate signers.
Can I use Remote Online Notarization (RON)?
Maybe. RON availability varies by state and document type; verify state RON status, identity-proofing, and audio-video recording retention requirements before proceeding.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now